▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / DQWS

DQWS — DSwiss Inc

—
OTC · Materials · Chemicals · CIK 1652561 ·
Last close
$0.04
Market Cap
$8.69M
52W High
$0.09
52W Low
$0.03
ADV30
443
Next earnings
—
DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 477,737 159,192 10,478 4,291 687,604 220,027 693,393
Dec 2025 456,842 94,338 -147,443 -149,833 677,136 285,034 686,482
Sep 2025 441,618 58,569 -88,004 -97,891 800,748 367,519 652,155
Jun 2025 1,021,340 148,608 6,829 32,128 951,722 580,951 701,647

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-94,303
Investing CF
$-8,482
Financing CF
$-34,728
CapEx
$-41,031
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,464,790
Inventory
$2,347
Receivables
$21,262
ST Investments
—
EBIT TTM
$-46,540
Pretax Income TTM
$-60,888
Interest Exp TTM
$14,348
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,397,537
EBITDA
$-162,742
Free Cash Flow
$47,557
Enterprise Value
$8,805,528
Total Cash
$234,940
Total Debt
$267,714
Shares Out
206,904,585
Trailing EPS
$0.00
Book Value
$0.00
ROE
-203.8%
ROA
-17.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,920,986 -86,715 -76,860 677,136 686,482 — -94,303
Dec 2024 3,112,887 18,348 22,223 635,830 561,794 — 182,556
Dec 2023 1,470,071 -52,863 -49,535 367,493 311,078 — 45,295
Dec 2022 1,849,047 -1,032 -14,291 381,924 283,773 — 22,428

Peers — same industry

TickerNameMarket CapLastDaily %
PURE PURE BIOSCIENCE, INC. $8.70M $0.07 —
ORGN Origin Materials, Inc. $7.98M $1.45 —
YCBD cbdMD, Inc. $7.98M $0.76 —
SNES SenesTech, Inc. $9.65M $1.82 —
BON Bon Natural Life Ltd $7.79M $1.28 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →